Navigation Links
A drug in vogue to deccelerate the course of Alzheimer's

Alzheimer’s disease continues to fuel research, as the incidence is likely to increase in the future. A new drug has been developed to slow the course of Alzheimer's disease. There is a special chemical called glutamate, which is one of the brain’s messenger and this chemical//is regulated by a drug called Memantine. Learning and memory are the fields, which are enabled by the chemical glutamate. This happens when glutamate is in its normal concentration. Its concentration can increase or decrease according to the level of Alzheimer's disease.

Available treatments for Alzheimer's that have proven effective at treating mild to moderate stages of the disease are aimed at a different chemical system in the brain, the cholinergic system. Memantine has been approved for use in Germany for more than 10 years.

The Food and Drug Administration is reviewing its safety and efficacy for possible U.S. sale of this drug. Approval could happen by this fall. Findings from a randomized, double-blind study of the drug in 252 patients were published in the April 3 New England Journal of Medicine.

Patients who took Memantine seemed to decline about half as much during the six-month trial as would ordinarily be expected, said Barry Reisberg, MD, professor of psychiatry at New York University School of Medicine, who led the study. Another issue that must be teased out is whether antioxidants in a pill are as beneficial as those in food, noted Paula Bickford, PhD, professor of neurosurgery at the University of South Florida, Tampa.
'"/>




Page: 1

Related medicine news :

1. Sun screen in vogue: for fashion and for health!
2. Postpone intercourse after childbirth
3. Satisfied Sexual Intercourse for Impotence men with Penile Prosthesis
4. Schools set to offer Japanese language course
5. A New Study Discredits The Myth Of Sexual Intercourse Late In Pregnancy Speeds Labour & Delivery
6. Indias Law on Homosexuality Needs Recourse - Hampers HIV Prevention
7. Timing of First Intercourse is Vital
8. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
9. Decrease in testosterone levels lead to Alzheimers
10. Smokers are prone to Alzheimers
11. Over-The-Counter Drugs May Prevent Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality ... Management Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively ... Management Alerts and Dashboards provide near real-time data about patients admitted to and/or ...
(Date:6/23/2017)... , ... June 23, 2017 , ... By scoring 100% ... ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's work ... 1% of all charities reviewed by Charity Navigator and earns ANRF a spot on ...
(Date:6/23/2017)... , ... June 24, 2017 , ... Studies show evidence ... reduce the risk of visual loss in these patients. , But how often do ... or smoking cessation to patients at risk of or with early symptoms of AMD? ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... plastic surgeon practicing in Newburgh, New York, has recently begun offering three new ... to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... June 1, 2017 Nutriceutical Holdings (NH), parent ... Solutions (VRS), and KD Pharma Group have decided to ... by KD Pharma Group. KD Pharma Group will become ... to acquire the entire company. "We believe ... are committed to growing the NH companies by providing ...
(Date:5/26/2017)... 26, 2017  Endo International plc (NASDAQ: ENDP ... CEO, will represent the Company in a fireside chat at ... Tuesday, June 13, 2017 at 10:40 a.m. PT / 1:40 ... in Rancho Palos Verdes, CA. ... will be available on the Company,s website at http://www.endo.com/investors/overview ...
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
Breaking Medicine Technology: